You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Gene Expression

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Type 2 Trial in Nezahualcóyotl (Gemigliptin, Gemigliptin 50 mg q.d. + metformin 1000 mg twice a day, Metformin)

Completed
  • Diabetes Mellitus, Type 2
  • Nezahualcóyotl, Estado de México, Mexico
    Unidad de Farmacología Clínica de la Facultad de Medicina de la
Oct 13, 2017

Peripheral Vascular Diseases Trial in Galway, Limerick (Remote Ischemic Preconditioning)

Suspended
  • Peripheral Vascular Diseases
  • Remote Ischemic Preconditioning
  • Galway, Co Galway, Ireland
  • +1 more
Sep 22, 2017

Insulin Resistance and Type 2 Diabetes Trial in Ann Arbor (Weight loss - diet only, Weight loss plus exercise)

Completed
  • Insulin Resistance and Type 2 Diabetes
  • Weight loss - diet only
  • Weight loss plus exercise
  • Ann Arbor, Michigan
    University of Michigan
Oct 12, 2017

Melanoma Trial (Palbociclib)

Unknown status
  • Melanoma
  • (no location specified)
Feb 27, 2018

Rett Syndrome Trial in Boston (Recombinant Human Insulin Growth Factor 1 (rhIGF-1), Placebo)

Completed
Has Results
  • Rett Syndrome
  • Recombinant Human Insulin Growth Factor 1 (rhIGF-1)
  • Placebo
  • Boston, Massachusetts
    Boston Children's Hospital
Mar 23, 2018

Solid Tumors Trial in Milano (BKM120-CIS, BKM120-CARBO)

Completed
  • Solid Tumors
  • Milano, MI, Italy
    Ospedale San Raffaele
Jun 18, 2018

Social Psychology Trial in Los Angeles (Writing: Group 1, Writing: Group 2)

Completed
  • Social Psychology
  • Writing: Group 1
  • Writing: Group 2
  • Los Angeles, California
    UCLA Clinical & Translational Research Center (CTRC)
May 1, 2017

Sleep Disorders, Circadian Rhythm Trial in Aachen, Hamburg, Rome (Melatonin 2mg, Placebo)

Completed
  • Sleep Disorders, Circadian Rhythm
  • Melatonin 2mg
  • Placebo
  • Aachen, North Rhine-Westphalia, Germany
  • +2 more
May 24, 2017

Chronic Myeloid Leukemia Patients Trial (Measurement level of myeloid derived suppressor cells in CML patients treated with

Unknown status
  • Chronic Myeloid Leukemia Patients
  • Measurement level of myeloid derived suppressor cells in CML patients treated with imatinibe 400 mg/day
  • Measurement level of myeloid derived suppressor cells in CML patients treated with nilotinib 600 mg/day
  • (no location specified)
Jul 8, 2017

Diabetes, Type 2 Trial in Dundee (gliclazide)

Terminated
  • Diabetes Mellitus, Type 2
  • Dundee, United Kingdom
    NHS Tayside
May 1, 2018

Malaria, Antepartum Trial in Abomey-Calavi (PAMVAC, Alhydrogel, GLA-SE)

Completed
  • Malaria, Antepartum
  • PAMVAC
  • +4 more
  • Abomey-Calavi, Benin
    Institut de Recherche Clinique du Benin (IRCB)
Jun 22, 2018

Resectable Breast Cancer Trial in Philadelphia (EC17)

Completed
  • Resectable Breast Cancer
  • Philadelphia, Pennsylvania
    Hospital of the University of Pennsylvania
Jun 29, 2018

High Myopia, Gene Mutations Trial (TGFB1 AND LAMA1 GENE POLYMORPHISMS)

Completed
  • High Myopia
  • Gene Mutations
  • TGFB1 AND LAMA1 GENE POLYMORPHISMS
  • (no location specified)
Mar 2, 2018

Pneumonia, Pneumococcal Trial in Kilifi (Pneumovax)

Completed
  • Pneumonia, Pneumococcal
  • Pneumovax
  • Kilifi, Coast, Kenya
    Kilifi District Hospital
Mar 8, 2018

Chronic Kidney Diseases Trial in Aachen (endoscopy)

Terminated
  • Chronic Kidney Diseases
  • endoscopy
  • Aachen, NRW, Germany
    University Hospital Aachen
Nov 22, 2017

Postoperative Care/Methods, Drainage/Methods, Edema/Prevention & Control Trial in Ghent (manual lymphatic drainage)

Completed
  • Postoperative Care/Methods
  • +3 more
  • manual lymphatic drainage
  • Ghent, Belgium
    University of Ghent
Jan 31, 2019

Melanoma Trial in Dallas (Trametinib (2mg)/Digoxin (.25mg))

Completed
  • Melanoma
  • Trametinib (2mg)/Digoxin (.25mg)
  • Dallas, Texas
    UT Southwestern Medical Center
May 9, 2018

Head and Neck Squamous Cell Carcinoma Trial in San Francisco, Chicago (Tavokinogene Telseplasmid (tavo), OncoSec Medical System

Terminated
Has Results
  • Head and Neck Squamous Cell Carcinoma
  • Tavokinogene Telseplasmid (tavo)
  • OncoSec Medical System (OMS)
  • San Francisco, California
  • +1 more
Dec 31, 2017

Platelet Glycoproteins in Inherited Thrombocytopathy:

Unknown status
  • Bleeding
  • Platelet Dysfunction
  • Flowcytometry analysis of platelets surface receptors
  • Assiut, Egypt
    Assiut University Hospital
Aug 24, 2018

Blood Transfusion, Endothelial Physiopathology, Nitric Oxide Trial in Boston (Red blood Cells auto-transfusion, Inhaled Nitric

Completed
Has Results
  • Blood Transfusion
  • +3 more
  • Red blood Cells auto-transfusion
  • Inhaled Nitric Oxide (iNO) administration
  • Boston, Massachusetts
    Massachusetts General Hospital
Apr 17, 2017

HER2 Positive Malignancies Trial in Houston (TGFBeta resistant HER2/EBV-CTLs)

Completed
  • HER2 Positive Malignancies
  • TGFBeta resistant HER2/EBV-CTLs
  • Houston, Texas
  • +1 more
Sep 15, 2018

Exome Analysis in Hearing Impaired Patients

Unknown status
  • Hearing Impairment
  • Exome sequencing
  • Montpellier, France
    Uhmontpellier
Jun 14, 2018

Donepezil, Drug Plasma Concentration and CYP2D6 and APOE Genetic

Completed
  • Late Onset Alzheimer Disease
    • (no location specified)
    Dec 14, 2017

    HIV Infected Patients With Cancer Treated by ICPi Trial in France (Blood sample)

    Unknown status
    • HIV Infected Patients With Cancer Treated by ICPi
    • Blood sample
    • La Réunion, Saint-Denis, France
    • +55 more
    Jan 24, 2018

    Small RNA Pathways in Mammalian Gametogenesis

    Unknown status
    • Male Infertility
      • New York, New York
        Weill Cornell Medicine
      May 3, 2018